BLEOMYCIN Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A glycopeptide antibiotic produced by the bacterium Streptomyces verticillus. The term, 'bleomycin' refers to a family of structurally related compounds. When used as an anti-cancer agent, the chemotherapeutical forms are primarily bleomycin A2 and B2. (Chemical Entities of Biological Interest Ontology, CHEBI_22907)
External Link https://dgidb.org/results?searchType=drug&searchTerms=BLEOMYCIN
Similar Terms
Downloads & Tools

Genes

16 interacting proteins for the BLEOMYCIN drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
LIG1 ligase I, DNA, ATP-dependent 6.6165
BLMH bleomycin hydrolase 3.30825
SMAD2 SMAD family member 2 0.827062
ADK adenosine kinase 0.6015
CCL17 chemokine (C-C motif) ligand 17 0.4411
GJA1 gap junction protein, alpha 1, 43kDa 0.4411
GSTM1 glutathione S-transferase mu 1 0.287674
AFP alpha-fetoprotein 0.26466
F2R coagulation factor II (thrombin) receptor 0.245056
IFNG interferon, gamma 0.213435
CTLA4 cytotoxic T-lymphocyte-associated protein 4 0.183792
PLAU plasminogen activator, urokinase 0.140777
MAPK8 mitogen-activated protein kinase 8 0.103383
WRN Werner syndrome, RecQ helicase-like 0.0778412
BRCA1 breast cancer 1, early onset 0.0719185
NFE2L2 nuclear factor, erythroid 2-like 2 0.00786742